Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Rekha Sinha"'
Autor:
Yannick Vandendijck, Jane Scott, Dirk Heerwegh, Wim Van Der Elst, James Witek, Rekha Sinha, Hein Fennema
Publikováno v:
Influenza Other Respir Viruses
BACKGROUND: The Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS) was developed to assess the severity of respiratory syncytial virus (RSV) infection in children. Because young children cannot report how th
Autor:
Rekha Sinha, Bindu Sharma
Publikováno v:
Bhartiya Krishi Anusandhan Patrika.
Background: Each region has its own traditional food habits. One of the ways to combat malnutrition is through enriching the traditional recipes, which are liked and accepted by the population. Thus, value addition was given to traditional recipes by
Autor:
Rekha Sinha, Bindu Sharma
Publikováno v:
International Journal of Chemical Studies. 8:234-237
An investigation was carried out to develop finger millet enriched vermicelli and their sensory and nutritional evaluation was carried out. Three types of vermicelli were prepared by replacing 70%, 50% and 60% of refined flour with finger millet of b
Autor:
Rekha Sinha
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 7:1323-1329
Autor:
Rob Arbuckle, R. Grimes, James Witek, E. Santucci-Hutcheson, S. Tatlock, Jane Scott, Rekha Sinha
Publikováno v:
Value in Health. 24:S242
Autor:
Jun Cheng, Sivi Ouwerkerk-Mahadevan, Qing Xie, Thierry Verbinnen, Eva Hoeben, Jia Shang, Lai Wei, James Witek, Oliver Lenz, Ju Hyun Kim, Jeong Heo, Mengchun Li, Xinyue Chen, Jane Scott, Monika Peeters, Dongliang Yang, R. Kalmeijer, Tao Han, Rekha Sinha
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:912-920
Background and Aim Approximately one-third of patients with hepatitis C virus (HCV) genotype (GT) 1 infection live in East Asia. This study evaluated the efficacy, pharmacokinetics, safety, and tolerability of simeprevir plus peginterferon alpha-2a a
Autor:
David E. Bernstein, Bart Fevery, Paul Y. Kwo, Eugene R. Schiff, Rekha Sinha, M. Davis, Ronald Nahass, Jane Scott, Norman Gitlin, James Witek, R. Kalmeijer, Monika Peeters, Sergio Rojter, Peter Ruane, Guy De La Rosa, K.P. Etzkorn, Oliver Lenz, Ziad Younes
Publikováno v:
Hepatology (Baltimore, Md.)
Effective antiviral therapy is essential for achieving sustained virological response (SVR) in hepatitis C virus (HCV)-infected patients. The phase 2 COSMOS study reported high SVR rates in treatment-naive and prior null-responder HCV genotype (GT) 1
Autor:
Robert Herring, Aasim Sheikh, Eric M. Yoshida, Reem Ghalib, Guy De La Rosa, Hillel Tobias, Eliot Godofsky, Oliver Lenz, Monika Peeters, Gary Matusow, Rekha Sinha, Jane Scott, Bart Fevery, James Witek, Eric Lawitz, Franco Felizarta, Gary Poleynard, R. Kalmeijer, Marcelo Kugelmas, Edwin DeJesus
Publikováno v:
Hepatology (Baltimore, Md.)
UNLABELLED Hepatitis C virus (HCV)-infected patients with cirrhosis are historically a difficult-to-treat population and are at risk of hepatic decompensation. In the phase 2 COSMOS study that evaluated simeprevir (HCV NS3/4A protease inhibitor) + so
Autor:
Bindu Sharma, Rekha Sinha
Publikováno v:
Asian Journal of Dairy and Food Research. 36
An investigation was carried out to develop finger millet based nutritious cookies and their sensory and nutritional evaluation was carried out. Two types of cookies were prepared by replacing 30 and 50 % of refined flour with finger millet. Both typ
Autor:
Jean-Pierre Bronowicki, Rekha Sinha, Xavier Forns, Edward Gane, Guy De La Rosa, Monika Peeters, Eric Lawitz, Pietro Andreone, Jane Scott, R. Kalmeijer, Maria Beumont–Mauviel, Sivi Mahadevan, Andrzej Horban, Stefan Zeuzem, Ashley Brown, Oliver Lenz
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2014, 146 (7), pp.1669-1679.e3. ⟨10.1053/j.gastro.2014.02.051⟩
Gastroenterology, WB Saunders, 2014, 146 (7), pp.1669-1679.e3. ⟨10.1053/j.gastro.2014.02.051⟩
BACKGROUND & AIMS: Simeprevir is an oral, once-daily inhibitor of hepatitis c virus (HCV) protease NS3/4A. We investigated the safety and efficacy of simeprevir with peg-interferon α-2a and ribavirin (PR) in a randomized, double-blind, placebo-contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0727b8a0f239c088da49fa609a0b5bb9
http://hdl.handle.net/11585/396849
http://hdl.handle.net/11585/396849